National Toxic Tort Trial Leader in Asbestos and Talc.

Bruce is a trial-tested products liability and toxic tort lawyer with a national practice centered on asbestos and cosmetic talc defense. Manufacturers and insurers turn to him for high-stakes trials, where he translates complex medical and industrial science into clear, credible stories for judges and juries. He has taken and defended thousands of depositions and trial examinations of key defense and plaintiff experts in traditional asbestos and cosmetic talc litigation.

Bruce has served as lead counsel in numerous Daubert evidentiary hearings across the United States and has helped develop new experts in multiple scientific disciplines relevant to toxic-tort cases. His experience spans a wide range of products and exposures, including insulation, joint compound, friction products, premises, welding rods, cosmetic talc, aircraft engines, bulk suppliers, electrical supply, floor tiles, mastics, and phenolic molding/plastics. Clients value Bruce’s rigorous preparation, precise communication, and steady judgment when the facts are complex and the stakes are high.

Notable Work & Achievements

Bruce’s practice sits at the intersection where complex science meets high-exposure litigation. As trial counsel in dozens of jurisdictions for Honeywell International, Dow/Union Carbide, and Johnson & Johnson, he defends personal-injury, wrongful-death, and property-damage claims that cut across products, transportation, aviation, and industrial operations. His record includes the first building-occupant asbestos personal-injury verdict (a defense win), statewide abatement suits in two states (including a $150 million West Virginia action), and large consolidations across three states. Bruce has tried and coordinated matters in 20+ states, from federal bankruptcy court to Daubert proceedings, and led national expert teams across core medical and engineering disciplines. In parallel, he litigates CERCLA cost recovery and coverage triggers—deploying allocation, trigger, and indemnity strategies grounded in the evidentiary record to reduce exposure and protect enterprise value.